HOT TOPICS IN CARDIOLOGY: Issue 5, 2007
Angiotensin AT1 receptor antagonists in patients at high risk for cardiovascular events: the state of the art
Angiotensin AT1 receptor antagonists in patients at high risk for cardiovascular events: the state of the art
Thomas Unger, Jan H. Schefe
Correspondence to:
Thomas Unger - M.D.
Professor of Pharmacology
Center for Cardiovascular Research (CCR)/ Institute of Pharmacology
Charité - Universitätsmedizin Berlin
Campus Charité-Mitte
Berlin, Germany
E-mail:
thomas.unger@charite.de